Heparin‐induced thrombocytopenia ‐ not measured · people > 18 years of age with a diagnosed deep vein thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All harmful effects · people > 18 years of age with a diagnosed deep vein thrombosis
It is very uncertain whether fondaparinux plus vitamin K antagonist changes all harmful effects compared with standard therapy (very low certainty).
1 finding from 1 review
Mortality ‐ not reported · People with cancer with perioperative thromboprophylaxis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total VTE · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in any VTE compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Major bleeding · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in major Bleeding compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Minor bleeding · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in minor Bleeding compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Thrombocytopenia · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in thrombocytopenia compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Pulmonary embolism · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in any Pulmonary embolism compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Postoperative drain volume · People with cancer with perioperative thromboprophylaxis
1 finding from 1 review